课题基金 / 基金详情

RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials - The MMRD-GREEN trial

RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials - The MMRD-GREEN trial
RAINBO：基于分子特征的 TransPORTEC 平台试验完善子宫内膜癌的辅助治疗 - MMRD-GREEN 试验
批准号：
462812
负责人：
Parulekar Wendy R
金额：
$55.45万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-03-01 至 2028-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=462812&lang=en
关键词：
Adjuvant Therapy Endometrial Cancer Immunotherapy Mismatch Repair Deficiency Molecular Classification Personalized Medicine Predictive Biomarkers Quality Of Life Randomized Phase Iii Trial

项目摘要

项目成果

Parulekar Wendy R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Endometrial cancer (EC) is the most common gynecologic malignancy and the fourth most-commonly diagnosed cancer in Canadian women. The incidence of EC is rising worldwide. Based on 2021 Canadian Cancer Statistics, about 8000 women were diagnosed with EC a
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimizing head and Neck Tumour And Symptom Control in Patients Unable to Tolerate Curative (Radio)Therapy: a Phase III trial Comparing Stereotactic Body Radiation Therapy (SBRT) to Standard Palliative Radiation Treatment (ON-TASC Study)
SPECT-CT Guided ELEctive Contralateral Neck Treatment (SELECT) for Patients with Lateralized Oropharyngeal Cancer: A Phase III Randomized Controlled Trial
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
海外基金